Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

v3.22.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Dec. 31, 2021
Mar. 31, 2021
Current assets    
Cash $ 20,394,536 $ 9,861,575
Accounts receivable 131,966 149,082
Prepaid expenses and other current assets 683,722 341,081
Total current assets 21,210,224 10,351,738
Property and equipment, net 254,024 160,976
Right-of-use lease asset 328,869 40,363
Patents, net 2,338 56,954
Restricted cash 87,506 46,726
Deposits 33,305 12,159
Total assets 21,916,266 10,668,916
Current liabilities    
Accounts payable 234,118 337,678
Due to related parties 130,375 118,520
Deferred revenue 229,698 114,849
Lease liability, current portion 53,545 42,543
Other current liabilities 421,956 761,636
Total current liabilities 1,069,692 1,375,226
Lease liability, less current portion 287,221
Total liabilities 1,356,913 1,375,226
Stockholders’ Equity    
Common stock, par value $0.001 per share; 30,000,000 shares authorized; 15,408,231 and 12,150,597 shares issued and outstanding as of December 31, 2021 and March 31, 2021, respectively 15,410 12,152
Additional paid-in capital 147,229,134 129,331,542
Accumulated deficit (126,544,103) (119,913,090)
Total Aethlon Medical, Inc. stockholders’ equity before noncontrolling interests 20,700,441 9,430,604
Noncontrolling interests (141,088) (136,914)
Total stockholders’ equity 20,559,353 9,293,690
Total liabilities and stockholders’ equity $ 21,916,266 $ 10,668,916